In this study, the clinical data of 4467 patients with NSCLC had been collected in southwest of China, and the total mutation rate of EGFR gene was 46.7%, similar to the 48.7% EGFR mutation rate reported by the West China Hospital of Sichuan University in China. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.